387 related articles for article (PubMed ID: 22240256)
21. Elevated Expression of miR-19b Enhances CD8
Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
Front Immunol; 2018; 9():3140. PubMed ID: 30687333
[TBL] [Abstract][Full Text] [Related]
22. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker.
Yousefpouran S; Mostafaei S; Manesh PV; Iranifar E; Bokharaei-Salim F; Nahand JS; Mirzaei H; Taran M; Babaei F; Sayad B; Moghoofei M
Microb Pathog; 2020 Oct; 147():104355. PubMed ID: 32569788
[TBL] [Abstract][Full Text] [Related]
23. Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.
Weber J; Gibson RM; Sácká L; Strunin D; Hodek J; Weberová J; Pávová M; Alouani DJ; Asaad R; Rodriguez B; Lederman MM; Quiñones-Mateu ME
AIDS Res Ther; 2017; 14():15. PubMed ID: 28331526
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitro.
Reynoso R; Laufer N; Hackl M; Skalicky S; Monteforte R; Turk G; Carobene M; Quarleri J; Cahn P; Werner R; Stoiber H; Grillari-Voglauer R; Grillari J
Sci Rep; 2014 Aug; 4():5915. PubMed ID: 25081906
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral Suppression.
Di Carlo D; Falasca F; Mazzuti L; Guerrizio G; Migliara G; Santori M; Lazzaro A; Mezzaroma I; D'Ettorre G; Fimiani C; Iaiani G; Antonelli G; Turriziani O
AIDS Res Hum Retroviruses; 2024 May; 40(5):321-329. PubMed ID: 37523231
[TBL] [Abstract][Full Text] [Related]
26. Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
Taborda NA; Cataño JC; Delgado JC; Rugeles MT; Montoya CJ
J Acquir Immune Defic Syndr; 2012 May; 60(1):12-9. PubMed ID: 22240462
[TBL] [Abstract][Full Text] [Related]
27. Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.
Malhotra P; Haslett P; Sherry B; Shepp DH; Barber P; Abshier J; Roy U; Schmidtmayerova H
Sci Rep; 2019 Apr; 9(1):5963. PubMed ID: 30979916
[TBL] [Abstract][Full Text] [Related]
28. Identification of Host Micro RNAs That Differentiate HIV-1 and HIV-2 Infection Using Genome Expression Profiling Techniques.
Devadas K; Biswas S; Haleyurgirisetty M; Ragupathy V; Wang X; Lee S; Hewlett I
Viruses; 2016 May; 8(5):. PubMed ID: 27144577
[TBL] [Abstract][Full Text] [Related]
29. Elite and viremic HIV-1 controllers in West Africa.
N'takpé JB; Gabillard D; Moh R; Gardiennet E; Toni TD; Kouame GM; Badje A; Emieme A; Karcher S; Le Carrou J; Ménan H; Danel C; Eholie SP; Rouzioux C; Anglaret X; Lambotte O
AIDS; 2022 Jan; 36(1):29-38. PubMed ID: 34524145
[TBL] [Abstract][Full Text] [Related]
30. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.
Lassen KG; Lobritz MA; Bailey JR; Johnston S; Nguyen S; Lee B; Chou T; Siliciano RF; Markowitz M; Arts EJ
PLoS Pathog; 2009 Apr; 5(4):e1000377. PubMed ID: 19360131
[TBL] [Abstract][Full Text] [Related]
31. CD4+ T-cell recovery and clinical outcome in HIV-1-infected patients exposed to multiple antiretroviral regimens: partial control of viremia is associated with favorable outcome.
Brigido L; Rodrigues R; Casseb J; Custodio RM; Fonseca LA; Sanchez M; Duarte AJ
AIDS Patient Care STDS; 2004 Apr; 18(4):189-98. PubMed ID: 15142349
[TBL] [Abstract][Full Text] [Related]
32. Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
Van Gulck E; Bracke L; Heyndrickx L; Coppens S; Atkinson D; Merlin C; Pasternak A; Florence E; Vanham G
PLoS One; 2012; 7(5):e37792. PubMed ID: 22666392
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
[TBL] [Abstract][Full Text] [Related]
34. Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART.
Baldanti F; Paolucci S; Gulminetti R; Maserati R; Migliorino G; Pan A; Maggiolo F; Comolli G; Chiesa A; Gerna G
Antiviral Res; 2001 Jun; 50(3):197-206. PubMed ID: 11397507
[TBL] [Abstract][Full Text] [Related]
35. Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.
Buckheit RW; Allen TG; Alme A; Salgado M; O'Connell KA; Huculak S; Falade-Nwulia O; Williams TM; Gallant JE; Siliciano RF; Blankson JN
Nat Commun; 2012 Mar; 3():716. PubMed ID: 22395607
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research.
Rompalo AM; Astemborski J; Schoenbaum E; Schuman P; Carpenter C; Holmberg SD; Warren DL; Farzadegan H; Vlahov D; Smith DK
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):448-54. PubMed ID: 10225226
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
[TBL] [Abstract][Full Text] [Related]
38. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
Pernas M; Tarancón-Diez L; Rodríguez-Gallego E; Gómez J; Prado JG; Casado C; Dominguez-Molina B; Olivares I; Coiras M; León A; Rodriguez C; Benito JM; Rallón N; Plana M; Martinez-Madrid O; Dapena M; Iribarren JA; Del Romero J; García F; Alcamí J; Muñoz-Fernández M; Vidal F; Leal M; Lopez-Galindez C; Ruiz-Mateos E
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212942
[TBL] [Abstract][Full Text] [Related]
39. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
[TBL] [Abstract][Full Text] [Related]
40. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
Nokta MA; Li XD; Nichols J; Mallen M; Pou A; Asmuth D; Pollard RB
AIDS; 2001 Jan; 15(2):161-9. PubMed ID: 11216923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
